Clinical trial

A Study of LY2216684 in Participants With Impaired Hepatic Function

NCT01241435

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-10-01

PhasePHASE1

Study timeline

Study start (unknown)2010-10-01Date precision: month

Registry last updated2018-10-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Depressive Disorder, Majorunresolved

Interventions

LY2216684DRUG

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

MiamiFlorida, United States1 San AntonioTexas, United States1 OrlandoFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01241435 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.